Medicare Enrolled

Dr. Jeffrey Unger, M.D.

Endocrinology · Chino, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
14726 RAMONA AVE, Chino, CA 91710
9095908409
In practice since 2006 (19 years)
NPI: 1003856188 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Unger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Unger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Unger

Dr. Jeffrey Unger is an endocrinology specialist in Chino, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Unger performed 843 Medicare services across 392 unique beneficiaries.

Between the years covered by Open Payments, Dr. Unger received a total of $778,639 from 40 pharmaceutical and/or device companies across 1131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Unger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 47% volume in CA $778,639 industry payments

Medicare Practice Summary

Medicare Utilization ↗
843
Medicare services
Top 47% in CA for endocrinology
392
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
304 $63 $100
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
105 $1 $12
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
75 $25 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
67 $83 $150
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
62 $8 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
59 $126 $201
Quadrivalent influenza vaccine, preservative-free
A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose.
30 $22 $40
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
30 $32 $40
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
30 $25 $60
Annual depression screening 20 $18 $40
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
19 $9 $35
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
15 $11 $100
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
14 $115 $225
New patient office visit, complex (60-74 min) 13 $170 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$778,639
Total received (2018-2024)
Avg $111,234/year across 7 years
Top 1% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
1,131
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$701,608 (90.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$42,889 (5.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,142 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$87,712
2023
$131,116
2022
$147,621
2021
$114,826
2020
$90,289
2019
$133,977
2018
$73,098

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$33,002
Corcept Therapeutics
$31,009
Novo Nordisk Inc
$22,639
Novo Nordisk AS
$375
Insulet Corporation
$156
RECORDATI_RARE_DISEASES_INC.
$155
Bayer Healthcare Pharmaceuticals Inc.
$124
Alkermes, Inc.
$110
Xeris Pharmaceuticals, Inc.
$94
SANOFI-AVENTIS U.S. LLC
$31
JAZZ PHARMACEUTICALS INC.
$17
Top 3 companies account for 98.8% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$301,451
Novo Nordisk Inc
$292,206
Novo Nordisk AS
$42,687
Corcept Therapeutics
$32,409
Amgen Inc.
$24,906
Bayer HealthCare Pharmaceuticals Inc.
$20,811
SANOFI-AVENTIS U.S. LLC
$10,702
Janssen Pharmaceuticals, Inc
$8,936
LIFESCAN, INC.
$7,470
Bayer Healthcare Pharmaceuticals Inc.
$7,135
Allergan, Inc.
$5,697
Teva Pharmaceuticals USA, Inc.
$5,397
CeQur Corporation
$4,115
Medtronic, Inc.
$3,900
Astellas Pharma US Inc
$2,388
Zealand Pharma US, Inc.
$2,000
AstraZeneca Pharmaceuticals LP
$1,750
Dexcom, Inc.
$1,400
Titan Pharmaceuticals, Inc.
$450
ACADIA Pharmaceuticals Inc
$312
JAZZ PHARMACEUTICALS INC.
$220
Radiometer America, Inc
$195
Alkermes, Inc.
$195
Radius Health, Inc.
$190
GENZYME CORPORATION
$185
Lilly USA, LLC
$185
Insulet Corporation
$156
RECORDATI_RARE_DISEASES_INC.
$155
Esperion Therapeutics, Inc.
$152
AbbVie Inc.
$143
Indivior Inc.
$131
Mannkind Corporation
$120
Antares Pharma, Inc.
$120
Tandem Diabetes Care, Inc.
$109
Xeris Pharmaceuticals, Inc.
$94
MannKind Corporation
$59
HARMONY BIOSCIENCES LLC
$45
Lexicon Pharmaceuticals, Inc.
$34
Axsome Therapeutics, Inc.
$19
Allergan Inc.
$10
Top 3 companies account for 81.7% of all-time payments
Associated products mentioned in payments ›
AFINION 2 · AFREZZA · AJOVY · Afinion 2 · Aimovig · BYSTOLIC · CeQur Simplicity · DEXCOM G6 CGM SYSTEM · EMGALITY · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · Hb801 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · Kerendia · Korlym · NEXLETOL · NEXLIZET · NO PRODUCT DISCUSSED · NOCDURNA · NUPLAZID · Non-Covered · OTREXUP · Omnipod · Otezla · Ozempic · Probuphine · QULIPTA · RECORLEV · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SUBLOCADE · Saxenda · Sunosi · TOUJEO · TZIELD · Tresiba · Tymlos · UBRELVY · VIVITROL · VRAYLAR · Victoza · Vivitrol · Wakix · Wegovy · XYWAV · Xultophy 100/3.6 · ZEGALOGUE · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in CA.

Looking for an endocrinology specialist in Chino?
Compare endocrinologists in the Chino area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
97
Per 100K population
4.4
County median income
$82,184
Nearest hospital
CHINO VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Unger is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Unger experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Unger performed 304 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Unger receive payments from pharmaceutical companies?
Yes. Dr. Unger received a total of $778,639 from 40 companies across 1,131 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Unger's costs compare to other endocrinologists in Chino?
Dr. Unger's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Unger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →